Skip to main content
Retour
Watch Compare

VYCOR MEDICAL INC

Qualité des données : 100%
VYCO
OTC Manufacturing Measuring & Analyzing Instruments
0,10 €
0,00 € (0,00%)
Cap. Boursière: 3,24 M
Prix
0,10 €
Cap. Boursière
3,24 M
Fourchette du Jour
0,04 € — 0,08 €
Fourchette 52 Semaines
0,04 € — 0,50 €
Volume
41 000
Ouverture 0,06 €
Moyenne 50J / 200J
0,10 €
4,24% below
Moyenne 50J / 200J
0,13 €
27,93% below

Quick Summary

Points Clés

Revenue grew 7,54% annually over 5 years — modest growth
Negative free cash flow of -18 695,0
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9,70%
Capital efficient — spends only 0,28% of revenue on capex

Croissance

Revenue Growth (5Y)
7,54%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)17,24%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-3,89%
Op. Margin1,82%

Sécurité

Debt / Equity
N/A
Current Ratio0,14
Interest Coverage2,57

Valorisation

PE (TTM)
-44,70
En dessous de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDA33,96
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -44,7 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -3,9 -41,5
Rev Growth 5Y % 7,5 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 17,24% Revenue Growth (3Y) 12,95%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 7,54% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,86 M Net Income (TTM) -72 426,0
ROE N/A ROA -7,96%
Gross Margin 83,78% Operating Margin 1,82%
Net Margin -3,89% Free Cash Flow (TTM) -18 695,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,14
Interest Coverage 2,57 Asset Turnover 2,05
Working Capital -4,15 M Tangible Book Value -4,02 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -44,70 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1,74
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 33,96 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,58%
Market Cap 3,24 M Enterprise Value 3,17 M
Per Share
EPS (Diluted TTM) -0,01 Revenue / Share 0,06
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,28% FCF Conversion 25,81%
SBC-Adj. FCF -73 638 Growth Momentum 9,70

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,86 M 1,59 M 1,46 M 1,22 M 1,39 M
Net Income -72 426,0 -107 200,0 -69 691,0 -404 917,0 -435 662,0
EPS (Diluted) -0,01 -0,01 -0,01 — —
Gross Profit 1,56 M 1,42 M 1,32 M 1,08 M 1,26 M
Operating Income 33 900,0 -9 145,0 40 191,0 -306 514,0 -435 954,0
EBITDA — — — — —
R&D Expenses 9 963,0 15 325,0 22 558,0 15 159,0 15 159,0
SG&A Expenses 1,46 M 1,36 M 1,20 M 1,33 M 1,61 M
D&A 59 521,0 59 521,0 57 497,0 58 232,0 66 070,0
Interest Expense 13 200,0 13 200,0 13 200,0 13 200,0 13 200,0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 830 420,0 998 117,0 992 298,0 860 178,0 935 364,0
Total Liabilities 4,92 M 4,69 M 4,32 M 3,80 M 3,33 M
Shareholders' Equity -4,09 M -3,69 M -3,33 M -2,94 M -2,40 M
Total Debt — — — — 150 000,0
Cash & Equivalents 86 982,0 105 648,0 57 291,0 37 035,0 90 941,0
Current Assets 563 422,0 695 719,0 584 090,0 517 763,0 487 411,0
Current Liabilities 4,78 M 4,50 M 4,07 M 3,65 M 3,15 M